JCSE01.19 ALTER-0303 Study: Tumor Mutation Index (TMI) For Clinical Response to Anlotinib in Advanced NSCLC Patients at 3rd Line.

Details

Language :

English

ISSN :

15560864

Volume :

13

Database :

Complementary Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Academic Journal

Accession number :

132778432

Full Text :

https://doi.org/10.1016/j.jtho.2018.08.225